| __timestamp | Regeneron Pharmaceuticals, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 504755000 | 5496000 |
| Thursday, January 1, 2015 | 838526000 | 9786000 |
| Friday, January 1, 2016 | 1177697000 | 6792000 |
| Sunday, January 1, 2017 | 1320433000 | 7313000 |
| Monday, January 1, 2018 | 1556200000 | 8382000 |
| Tuesday, January 1, 2019 | 1834800000 | 10803000 |
| Wednesday, January 1, 2020 | 1346000000 | 12944000 |
| Friday, January 1, 2021 | 1824900000 | 21967000 |
| Saturday, January 1, 2022 | 2115900000 | 32810000 |
| Sunday, January 1, 2023 | 2631300000 | 46542000 |
| Monday, January 1, 2024 | 2954400000 |
Unlocking the unknown
In the competitive landscape of pharmaceuticals, understanding operational efficiency is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Regeneron Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc. over the past decade.
Regeneron, a giant in the industry, has seen its SG&A expenses grow from $505 million in 2014 to a staggering $2.63 billion in 2023, marking a 420% increase. This reflects its expansive growth and investment in administrative capabilities. In contrast, Xenon Pharmaceuticals, a smaller player, increased its SG&A expenses from $5.5 million to $46.5 million in the same period, an impressive 745% rise, albeit from a smaller base.
This comparison highlights the differing scales and growth strategies of these companies, offering insights into their operational priorities and market positioning.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Biogen Inc.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Bio-Techne Corporation
Operational Costs Compared: SG&A Analysis of Regeneron Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc.
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Dr. Reddy's Laboratories Limited
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc.
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc. Trends and Insights
Regeneron Pharmaceuticals, Inc. and Vericel Corporation: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Evotec SE
Cost Management Insights: SG&A Expenses for Neurocrine Biosciences, Inc. and Xenon Pharmaceuticals Inc.
Who Optimizes SG&A Costs Better? Insmed Incorporated or Xenon Pharmaceuticals Inc.
Axsome Therapeutics, Inc. and Xenon Pharmaceuticals Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.